EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Melatonin for migraine prevention in children and adolescents: A randomized, double‐blind, placebo‐controlled trial after single‐blind placebo lead‐in

Amy A Gelfand iD, I Elaine Allen iD, Barbara Grimes, Samantha Irwin iD, William Qubty, Kaitlin Greene, Maggie Waung, Scott W Powers, Christina L Szperka

Headache: The Journal of Head and Face Pain · 2023

DOI: 10.1111/head.14600 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Headache: The Journal of Head and Face Pain, 2023. Verfasst von Amy A Gelfand und 8 weiteren Autor:innen. Beteiligte Einrichtung: Child & Adolescent Headache Program, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Melatonin, Migraine Disorders. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Weill Institute for Neurosciences, University of California, San Francisco.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Melatonin is effective for migraine prevention in adults. We hypothesized that melatonin would also be effective for migraine prevention in children and adolescents.

Methods

This was a randomized, double‐blind trial of melatonin (3 mg or 6 mg) versus placebo for migraine prevention in 10–17 year‐olds with 4–28/28 headache days at baseline. Participants were recruited from the UCSF Child & Adolescent Headache Program, UCSF child neurology clinic, and social media advertisements. Migraine diagnosis was confirmed by a headache specialist. Participants completed an 8‐week single‐blind placebo run‐in. Those meeting randomization criteria (≥4 headache days and ≥23/28 electronic diary entries during weeks 5–8) were randomized 1:1:1 to placebo:melatonin 3 mg:melatonin 6 mg nightly for 8 weeks. The primary outcome measure was migraine days in weeks 5–8 of randomized treatment between melatonin (combined 6 mg + 3 mg) versus placebo. We aimed to enroll n = 210.

Results

The study closed early due to slow enrollment ( n = 72). Two participants were in the single‐blind phase when the study closed, therefore the meaningful n = 70. Sixteen percent (11/70) were lost to follow‐up during the single‐blind phase. An additional 21% (15/70) did not meet randomization criteria (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninMigraine DisordersAdultHumansAdolescentChildTreatment OutcomeSingle-Blind MethodHeadacheDouble-Blind Method

Stichwörter der Autor:innen

adolescentschildrenmelatoninmigraineplaceboprevention

Substanzen

Melatonin

Autor:innen und Institutionen

  • Child & Adolescent Headache Program, University of California San Francisco, San Francisco, California, USA.
  • Department of Neurology, University of California San Francisco, San Francisco, California, USA.
  • Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, California, USA.
  • Minneapolis Clinic of Neurology, Minneapolis, Minnesota, USA.
  • Department of Pediatrics, Oregon Health Sciences University, Portland, Oregon, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

ORCID-Profile: Amy A Gelfand, I Elaine Allen, Samantha Irwin

Förderung

  • Weill Institute for Neurosciences, University of California, San Francisco

Zitieren

APA

Gelfand, A. A., Allen, I. E., Grimes, B., Irwin, S., Qubty, W., Greene, K., Waung, M., Powers, S. W., & Szperka, C. L. (2023). Melatonin for migraine prevention in children and adolescents: A randomized, double‐blind, placebo‐controlled trial after single‐blind placebo lead‐in. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14600

Vancouver

Gelfand AA, Allen IE, Grimes B, Irwin S, Qubty W, Greene K, et al. Melatonin for migraine prevention in children and adolescents: A randomized, double‐blind, placebo‐controlled trial after single‐blind placebo lead‐in. Headache: The Journal of Head and Face Pain. 2023. doi:10.1111/head.14600

BibTeX
@article{Gelfand2023,
  author = {Gelfand, Amy A and Allen, I Elaine and Grimes, Barbara and Irwin, Samantha and Qubty, William and Greene, Kaitlin and Waung, Maggie and Powers, Scott W and Szperka, Christina L},
  title = {Melatonin for migraine prevention in children and adolescents: A randomized, double‐blind, placebo‐controlled trial after single‐blind placebo lead‐in},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2023},
  doi = {10.1111/head.14600}
}
Kostenlos starten →